This time last year, Depuy Orthopaedics, a subsidiary of Johnson & Johnson, had no idea that they would be on trial for one of this decade’s biggest products liability cases. A hearing has been scheduled in Louisville, Kentucky to determine whether to consolidate all federal Depuy Pinnacle cases to help in the discovery process. The number of victims who have had to undergo, in some cases, multiple revision surgeries has continued to steadily climb, and victims who were initially subdued with false data are now coming forward since the release of updated studies.
Product Manufacturer Negligence
Many Depuy defective product victims are just now finding out that their life-threatening injuries may be due to Johnson & Johnson’s negligence. Before the recalls, the makers of the defective hip replacement device released data collected from The British Orthopedic Association saying that an estimated thirteen percent of patients receiving a total hip replacement and twelve percent of patients receiving the hip resurfacing device would need to undergo revision surgery. These studies were questioned since their release, and have now been revised after a full collection of data was analyzed.